<PAGE> 1
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
March 27, 1995
------------------------------
REN Corporation - USA
- - --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Tennessee 0-18067 62-1323090
--------------- ---------------- -----------------
(State or Other (Commission File (I.R.S. Employer
Jurisdiction of Number) Identification
Incorporation) Number)
6820 Charlotte Pike
Nashville, Tennessee 37209
---------------------------------------- --------------
(Address of principal executive offices) (Zip Code)
(615) 353-4200
- - --------------------------------------------------------------------------------
(Registrant's telephone number, including area code)
================================================================================
<PAGE> 2
ITEM 5. OTHER EVENTS.
On March 27, 1995, the Registrant announced that it had
completed the previously announced purchase of the chronic and acute
dialysis programs operated by The George Washington University in
Washington, D.C., all as further described in the Registrant's press
release, a copy of which is filed herewith as Exhibit 20.1.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) EXHIBITS.
20.1 Press Release, dated March 27, 1995
2
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
REN CORPORATION - USA
By: /s/ Bradley S. Wear
------------------------------
Bradley S. Wear
Senior Vice President,
Chief Financial Officer
Date: April 7, 1995
3
<PAGE> 1
EXHIBIT 20.1
REN CORPORATION CLOSES PURCHASE
OF THE GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER
NASHVILLE, Tenn (March 27, 1995) -- REN Corporation-USA (NASDAQ/NM:RENL), one
of the nation's leading providers of kidney dialysis services, today announced
that it has completed the previously announced purchase of the chronic and
acute dialysis programs operated by The George Washington University in
Washington, D.C.
The purchase includes two clinics, which currently serve approximately
160 chronic and home patients in the Washington D.C. area. The purchase
resulted in the formation of the GW-REN Regional Dialysis Network.
Lawrence J. Centella, President and Chief Executive Officer of REN,
said, "REN is extremely pleased with the acquisition of the dialysis program at
The George Washington University Medical Center. This association allows us
the impetus to pursue aggressively managed care contracts not only within the
District, but throughout the United States. The prestige that George
Washington's dialysis program offers REN is equal to the programs of other
universities currently associated with REN."
Commenting on the agreement, Dr. Juan Bosch, medical director of the
GW-REN Regional Dialysis Network and medical director of the Division of Renal
Diseases & Hypertension at The George Washington University, said, "The
Washington, D.C. Metro area has the highest incidence of renal disease in the
country. Our program is well-known nationally and internationally as a pioneer
in advanced forms of treatment for patients with terminal renal failure. REN
has distinguished itself from other dialysis providers by the quality and
excellence of care it gives to dialysis patients.
"We are very excited that we have united our efforts to provide the
most advanced and dedicated care to the citizens of the metropolitan area,
especially the large number of African Americans who suffer from renal
diseases," said Dr. Bosch.
REN Corporation-USA currently owns and operates 60 kidney dialysis
centers, located across 17 states, and the District of Columbia. A number of
these centers are associated with prominent academic institutions. Overall,
the company's clinics have over 1,000 treatment stations servicing
approximately 5,000 patients. In 1994, REN performed more than 646,000
dialysis treatments. REN also performs blood and urine testing services for
its Centers, and others.
<PAGE> 2
For further information contact:
Steve Harrison, Executive Vice President
REN CORPORATION -USA, (615) 353-4200
2
